Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Syros Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Syros Pharma Raises USD10 Million in Venture Financing 13
Syros Pharma Raises USD40 Million in Venture Financing 14
Syros Pharma Raises USD53 Million in Series B Venture Financing 16
Syros Pharma Raises US$30 Million In Series A Financing 18
LS22 Raises USD1.25 Million in Venture Financing 19
LS22 Raises USD1.3 Million in Venture Financing 20
Partnerships 21
Incyte and Syros Pharma Enter into Agreement 21
Syros Pharma Amends Research Agreement With Multinational Pharmaceutical Company 22
Licensing Agreements 23
Syros Pharma Amends Licensing Agreement with TMRC 23
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 24
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 25
Syros Pharma Enters into Licensing Agreement with Dana-Farber Cancer Institute 27
Equity Offering 28
Syros Pharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD46 Million 28
Syros Pharma Raises USD1.2 Million in Private Placement of Shares 30
Syros Pharma Plans to Raise up to USD8.4 Million in Public Offering of Shares 31
Syros Pharma Plans to Raise Funds through Public Offering of Shares 32
Syros Pharma Raises USD35 Million in Private Placement of Shares 33
Syros Pharma Raises USD57.5 Million in IPO 34
Syros Pharmaceuticals Inc – Key Competitors 36
Syros Pharmaceuticals Inc – Key Employees 37
Syros Pharmaceuticals Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 07, 2018: Syros Reports Second Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones 39
May 10, 2018: Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones 41
Mar 12, 2018: Syros Announces Fourth Quarter and Full Year 2017 Financial Results 43
Nov 08, 2017: Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones 45
Aug 09, 2017: Syros Reports Second Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones 47
May 15, 2017: Syros Reports First Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones 49
Mar 20, 2017: Syros Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key Accomplishments and Upcoming Milestones 51
Corporate Communications 53
Mar 12, 2018: Syros Pharmaceuticals Appoints Joseph J. Ferra As Chief Financial Officer 53
Nov 13, 2017: Syros Announces Appointment of Jeremy P. Springhorn as Chief Business Officer 54
Jun 12, 2017: Syros Appoints Srinivas Akkaraju to Its Board of Directors 55
Jan 30, 2017: Syros Appoints Industry Leader Peter Wirth as Chair of Its Board of Directors 56
Government and Public Interest 57
Feb 27, 2017: Syros Reports Discovery of Novel Genomics Based Approach to Stratifying Patients with Acute Myeloid Leukemia at Cold Spring Harbor Conference 57
Product News 58
Jun 19, 2017: Syros Presents Discovery of Key Genes Controlling the Autoimmune Response in Lupus in Late-Breaking Oral Presentation at FOCIS Meeting 58
03/01/2017: Syros to Present New Data on CDK12/13 Inhibitor program at Upcoming AACR Annual Meeting 59
Other Significant Developments 60
Jan 08, 2018: Syros Announces 2018 Strategic Priorities and Expected Milestones 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syros Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Syros Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Syros Pharma Raises USD10 Million in Venture Financing 13
Syros Pharma Raises USD40 Million in Venture Financing 14
Syros Pharma Raises USD53 Million in Series B Venture Financing 16
Syros Pharma Raises US$30 Million In Series A Financing 18
LS22 Raises USD1.25 Million in Venture Financing 19
LS22 Raises USD1.3 Million in Venture Financing 20
Incyte and Syros Pharma Enter into Agreement 21
Syros Pharma Amends Research Agreement With Multinational Pharmaceutical Company 22
Syros Pharma Amends Licensing Agreement with TMRC 23
Syros Pharma Enters into Licensing Agreement with Whitehead Institute 24
Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 25
Syros Pharma Enters into Licensing Agreement with Dana-Farber Cancer Institute 27
Syros Pharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD46 Million 28
Syros Pharma Raises USD1.2 Million in Private Placement of Shares 30
Syros Pharma Plans to Raise up to USD8.4 Million in Public Offering of Shares 31
Syros Pharma Plans to Raise Funds through Public Offering of Shares 32
Syros Pharma Raises USD35 Million in Private Placement of Shares 33
Syros Pharma Raises USD57.5 Million in IPO 34
Syros Pharmaceuticals Inc, Key Competitors 36
Syros Pharmaceuticals Inc, Key Employees 37
Syros Pharmaceuticals Inc, Subsidiaries 38
List of Figures
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syros Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Syros Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer